David Sinclair: AI Might Solve Longevity, GLP-1 Side Effects, and Longevity Investing | MOONSHOTS
Watch the episode
1 min · YouTube
J
What they recommend · 1 pick
AI-driven drug design
AI tools
"We are working with companies and academics that do a lot of AI now. It's accelerating our work exponentially. AI-driven drug design and looking at billions and eventually trill..."
Peter, David, John and Jason agree on 13 things
J
See what they all use, in their own words. Ad reads don't count.
See what they all swear by Or pick your own people
◎
Related episodes
Episodes covering similar topics
Flying Tesla Car, Robot Brains Halving in Cost Every 3 Weeks, and Why Incentives Decide AI Alignment
OpenAI Bulk-Solves 722 Math Problems, Anthropic’s Cruelty Policy, & Elon’s Quadrillion-Dollar SpaceX
More from Peter Diamandis
Flying Tesla Car, Robot Brains Halving in Cost Every 3 Weeks, and Why Incentives Decide AI Alignment
Oct 17, 2026
OpenAI Bulk-Solves 722 Math Problems, Anthropic’s Cruelty Policy, & Elon’s Quadrillion-Dollar SpaceX
Oct 15, 2026
The Fight Over Claude's Consciousness, AI's 1942 Moment, & Why Altman Says "Accept Some Bad Things"
Oct 07, 2026
Astro Teller: Inside Google X's 2,000-Idea Moonshot Factory & How Google Brain Made the T in ChatGPT
Oct 05, 2026